Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer for Drug Co-Loading and SERS Monitoring.
cationic β-cyclodextrin-based polymer
drug co-loading
gold nanostars
phenylethylamine
piperine
surface-enhanced Raman scattering
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
15 Feb 2021
15 Feb 2021
Historique:
received:
13
01
2021
revised:
08
02
2021
accepted:
10
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
Gold nanostars (AuNSs) exhibit modulated plasmon resonance and have a high SERS enhancement factor. However, their low colloidal stability limits their biomedical application as a nanomaterial. Cationic β-cyclodextrin-based polymer (CCD/P) has low cytotoxicity, can load and transport drugs more efficiently than the corresponding monomeric form, and has an appropriate cationic group to stabilize gold nanoparticles. In this work, we functionalized AuNSs with CCD/P to load phenylethylamine (PhEA) and piperine (PIP) and evaluated SERS-based applications of the products. PhEA and PIP were included in the polymer and used to functionalize AuNSs, forming a new AuNS-CCD/P-PhEA-PIP nanosystem. The system was characterized by UV-VIS, IR, and NMR spectroscopy, TGA, SPR, DLS, zeta potential analysis, FE-SEM, and TEM. Additionally, Raman optical activity, SERS analysis and complementary theoretical studies were used for characterization. Minor adjustments increased the colloidal stability of AuNSs. The loading capacity of the CCD/P with PhEA-PIP was 95 ± 7%. The physicochemical parameters of the AuNS-CCD/P-PhEA-PIP system, such as size and Z potential, are suitable for potential biomedical applications Raman and SERS studies were used to monitor PhEA and PIP loading and their preferential orientation upon interaction with the surface of AuNSs. This unique nanomaterial could be used for simultaneous drug loading and SERS-based detection.
Identifiants
pubmed: 33671975
pii: pharmaceutics13020261
doi: 10.3390/pharmaceutics13020261
pmc: PMC7919026
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : ANID doctoral scholarship
ID : 21180548
Organisme : ANID-FONDECYT for postdoctoral research grant
ID : 3180706
Organisme : ANID-FONDAP
ID : 15130011
Organisme : FONDECYT
ID : 1170929
Organisme : Servicio General de Apoyo a las Investigación (SAI, University of Zaragoza)
ID : 0
Références
Eur J Pharm Sci. 2010 Jul 11;40(4):376-80
pubmed: 20434542
Nanotechnology. 2005 Oct;16(10):2360-4
pubmed: 20818018
Langmuir. 2020 Apr 7;36(13):3558-3564
pubmed: 32176502
Nano Lett. 2010 Sep 8;10(9):3223-30
pubmed: 20726522
J Chem Phys. 2005 Jan 1;122(1):14108
pubmed: 15638643
Nanomedicine. 2017 Oct;13(7):2341-2350
pubmed: 28673851
Nat Rev Drug Discov. 2004 Dec;3(12):1023-35
pubmed: 15573101
Mater Sci Eng C Mater Biol Appl. 2021 Feb;121:111785
pubmed: 33579441
Biomater Sci. 2020 Mar 31;8(7):1934-1950
pubmed: 32039412
Chem Rev. 2014 Nov 12;114(21):10940-75
pubmed: 25247843
Nanomaterials (Basel). 2020 Apr 06;10(4):
pubmed: 32268543
Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:231-9
pubmed: 27040215
J Mater Chem B. 2018 Aug 21;6(31):5091-5099
pubmed: 32254537
Acc Chem Res. 2008 Dec;41(12):1721-30
pubmed: 18712884
Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789
pubmed: 9944570
Small. 2015 Sep 9;11(34):4314-20
pubmed: 26034018
Int J Nanomedicine. 2017 Aug 22;12:6131-6152
pubmed: 28883725
Spectrochim Acta A Mol Biomol Spectrosc. 2019 May 5;214:79-85
pubmed: 30769154
J Pharm Sci. 2016 Sep;105(9):2921-2931
pubmed: 27317368
Chemistry. 2019 Jun 26;25(36):8471-8478
pubmed: 31012155
Carbohydr Polym. 2020 Apr 1;233:115865
pubmed: 32059912
Chem Pharm Bull (Tokyo). 2005 Jul;53(7):832-5
pubmed: 15997146
Nanoscale. 2012 Mar 21;4(6):1871-80
pubmed: 22076024
Webmedcentral. 2013 Sep 30;4(9):
pubmed: 24482732
Langmuir. 2015 Jul 28;31(29):8081-91
pubmed: 26154493
Langmuir. 2012 Mar 20;28(11):5040-7
pubmed: 22375834
Colloids Surf B Biointerfaces. 2018 Oct 1;170:303-311
pubmed: 29936383
ACS Appl Mater Interfaces. 2015 Jul 22;7(28):15177-88
pubmed: 26091143
ACS Nano. 2010 Jan 26;4(1):113-20
pubmed: 20014823
Anal Chem. 2015 Apr 7;87(7):3964-72
pubmed: 25723296
PLoS One. 2017 Oct 11;12(10):e0185652
pubmed: 29020065
Langmuir. 2015 Dec 8;31(48):13247-56
pubmed: 26522375
Anal Chim Acta. 2016 Mar 24;913:137-44
pubmed: 26944998
Theranostics. 2015 May 23;5(9):946-60
pubmed: 26155311
Theranostics. 2017 Apr 10;7(6):1650-1662
pubmed: 28529642
Angew Chem Int Ed Engl. 2005 Dec 9;44(48):7852-72
pubmed: 16304662
Anal Bioanal Chem. 2002 Sep;374(1):155-60
pubmed: 12207258
Chem Rev. 2004 Jan;104(1):293-346
pubmed: 14719978
Sci Rep. 2020 Jan 30;10(1):1487
pubmed: 32001750
Biomacromolecules. 2014 May 12;15(5):1837-44
pubmed: 24725005
Biosens Bioelectron. 2015 Dec 15;74:981-8
pubmed: 26264264
J Phys Chem C Nanomater Interfaces. 2015 Jul 30;119(30):17408-17415
pubmed: 28018519
Mol Pharm. 2017 Aug 7;14(8):2475-2486
pubmed: 28463008
Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098-3100
pubmed: 9900728
Int J Pharm. 2004 Jul 8;278(2):329-42
pubmed: 15196638
J R Soc Interface. 2010 Aug 6;7 Suppl 4:S435-50
pubmed: 20462878
Langmuir. 2012 Mar 20;28(11):5031-9
pubmed: 22375812
AAPS PharmSciTech. 2018 Feb;19(2):923-933
pubmed: 29071656
ACS Nano. 2015 Mar 24;9(3):3385-96
pubmed: 25723190
J Biol Chem. 1995 Jul 21;270(29):17250-6
pubmed: 7615524
Nanotechnology. 2012 Feb 24;23(7):075102
pubmed: 22260928
Drug Metab Rev. 2020 May;52(2):299-318
pubmed: 32150480
Anal Chem. 2018 Jan 2;90(1):760-768
pubmed: 29148719
Theranostics. 2013 Aug 03;3(9):633-49
pubmed: 24019851
Carbohydr Polym. 2017 Dec 1;177:22-31
pubmed: 28962762
Chem Soc Rev. 2012 Mar 21;41(6):2256-82
pubmed: 22130549
Biomaterials. 2016 Nov;106:87-97
pubmed: 27552319
Langmuir. 2010 Sep 21;26(18):14943-50
pubmed: 20804155
Nanoscale. 2019 Jan 23;11(4):2079-2088
pubmed: 30648720
Int J Med Chem. 2016;2016:8723139
pubmed: 26998357
Br J Sports Med. 2001 Oct;35(5):342-3
pubmed: 11579070
J Am Chem Soc. 2012 Jul 18;134(28):11358-61
pubmed: 22734608
Theranostics. 2015 Jun 01;5(9):970-84
pubmed: 26155313
Nanomaterials (Basel). 2018 Nov 28;8(12):
pubmed: 30486514
Langmuir. 2008 May 20;24(10):5233-7
pubmed: 18435552
Psychopharmacology (Berl). 2008 Dec;201(3):435-42
pubmed: 18766332
Adv Drug Deliv Rev. 2013 Aug;65(9):1215-33
pubmed: 23673149
Food Chem. 2016 Apr 1;196:968-75
pubmed: 26593579
Biomacromolecules. 2015 Oct 12;16(10):3345-56
pubmed: 26397308
Langmuir. 2005 Jun 21;21(13):5689-92
pubmed: 15952810